An evidence-based review of the status of HCT as treatment of sickle cell disease (SCD) and thalassemia presented in two case studies to introduce possible treatment algorithms based on peer-reviewed, published methods and outcomes of HCT for each disease. This review is designated as a CME article.
HCT in Sickle Cell Disease and Thalassemia: Evidence-Based Focused Review
May 2014